EDGEMOND JAMES sold UTHR
November 10, 2025 · Form 4 insider transaction
EDGEMOND JAMES sold 3,356 shares of United Therapeutics Corporation at $448.33 per share, a transaction worth $1.50M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,356
Price
$448.33
Total value
$1.50M
InsiderEDGEMOND JAMES
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 10, 2025
Filing dateNovember 12, 2025
Shares owned after23,171
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 5, 2025.